Article
[Antibody therapy in cancer].
Nihon rinsho. Japanese journal of clinical medicine - 1 Jun 2010
Komatsu Hirokazu
Abstract excerpt
Monoclonal antibody (MoAb) for cancer treatment has been greatly progressed during this decade. Six kinds of MoAbs are now in clinical use in Japan. Here we review on the development of MoAbs such as rituximab, bevacizumab and cetuximab. The characterization and the nomenclature of MoAb are also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
